Department: Board of Directors

Hans Bishop is the Chairman of Sana Biotechnology and a founder and President of Altos Labs, Inc. Prior to Altos Labs, Hans served as the Chief Executive Officer of GRAIL, Inc. from June 2019 until the Company’s acquisition by Illumina, Inc.  in October 2021. Hans co-founded Juno Therapeutics in 2013 and served as its President and Chief Executive Officer until the company’s acquisition by Celgene. […]

  • Posted in
  • Comments Off on Hans Bishop

Richard C. Mulligan, PhD, is Executive Vice Chairman of Sana Biotechnology. He is also the Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical School, and visiting scientist at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT). Most recently, Richard served as portfolio manager at Icahn Capital. Prior to that, […]

  • Posted in
  • Comments Off on Richard Mulligan, PhD

Steve Harr, MD, is President and Chief Executive Officer of Sana Biotechnology. Prior to co-founding Sana, Steve served as Chief Financial Officer and Head of Corporate Development for Juno Therapeutics until its acquisition by Celgene in early 2018. He was a member of the Board of Directors of Loxo Oncology prior to its acquisition by […]

  • Posted in
  • Comments Off on Steve Harr, MD

Josh Bilenker, MD, is the Chief Executive Officer and co-founder of Treeline Biosciences and a Director at Sana Biotechnology. Prior to launching Treeline, Josh was the CEO of Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company, and a Director at Sana Biotechnology. Josh joined Eli Lilly in 2019 when […]

  • Posted in
  • Comments Off on Josh Bilenker, MD

Doug Cole serves as a managing partner at Flagship Pioneering.  He joined Flagship Pioneering in 2001 and focuses on life science. He holds an A.B. magna cum laude with high distinction in English from Dartmouth College, where he was a senior fellow and a member of Phi Beta Kappa, and an M.D. from the University […]

  • Posted in
  • Comments Off on Doug Cole

Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners. In addition to Sana Biotechnology, he is a Director of Vir Biotechnology, GRAIL, Unity Biotechnology, and Denali Therapeutics, and he serves as Chairman of Hua Medicine, among others. He played a significant role in the early sourcing, financing and development of more […]

  • Posted in
  • Comments Off on Robert Nelsen, MBA